Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV003409041 | SCV004124828 | benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | LORICRIN: BP4, BS1, BS2 |
Ambry Genetics | RCV004364481 | SCV004897285 | uncertain significance | not specified | 2022-04-25 | criteria provided, single submitter | clinical testing | The c.763G>T (p.G255C) alteration is located in exon 2 (coding exon 1) of the LOR gene. This alteration results from a G to T substitution at nucleotide position 763, causing the glycine (G) at amino acid position 255 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |